Correction to Lancet Respir Med 2020; published online Dec 22. https://doi.org/10.1016/S2213-2600(20)30414-8

No authors listed

Published Erratum

No authors listed. Lancet Respir Med. 2021 Mar.

. 2021 Mar;9(3):e29.

doi: 10.1016/S2213-2600(21)00048-5. Epub 2021 Jan 25.

No abstract available

Erratum for

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.